Results 101 to 110 of about 12,797,283 (292)

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin   +11 more
wiley   +1 more source

Organized physical activity programs: improving motor and non-motor symptoms in neurodevelopmental disorders

open access: yes, 2018
Organized physical activity programs: improving motor and non-motor symptoms in neurodevelopmental ...
S Jeste (13596634)   +2 more
core  

Neurovascular Contacts in the Pathophysiology of Neuralgic Amyotrophy: An Observational Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuralgic amyotrophy (NA) is a prevalent, monophasic, multifocal immune‐mediated neuropathy. A distinctive characteristic of the disease is the occurrence of nerve or fascicle constrictions and torsions (NA‐associated focal nerve lesions, NAFL). The pathophysiology underlying this phenomenon remains to be fully elucidated.
Johannes Fabian Holle   +4 more
wiley   +1 more source

Non-motor Parkinson's:integral to motor Parkinson's, yet often neglected

open access: yes, 2014
Non-motor symptoms are a key component of Parkinson's disease, possibly representing a clinical biomarker of its premotor phase. The burden of non-motor symptoms can define a patient's health-related quality of life.
Ray Chaudhuri, K   +2 more
core   +1 more source

Treating non-motor symptoms in dystonia: a systematic review

open access: yesDystonia
IntroductionDystonia is characterized by dysfunctional movements and postures and current treatments aim to reduce unwanted muscle activity. Dystonia also encompasses non-motor symptoms which are becoming increasingly recognized as important contributors
Dana Sugar, Sarah Pirio Richardson
doaj   +1 more source

Association Between Motor Pathway Damage and Motor Deficit in Upper and Lower Limb in People With MS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Corticospinal tract damage is common in people with MS, but the degree of clinical symptoms varies. We hypothesize that corticospinal tract lesions are more extensive and severe in people with MS with motor impairments in both upper and lower limbs.
Mathilde Liffran   +13 more
wiley   +1 more source

Non-motor symptoms in Parkinson's disease:An underdiagnosed problem

open access: yes, 2006
Parkinson's disease results from degeneration of the substantia nigra pars compacta and the consequent dysfunction of the dopaminergic nigrostriatal pathway Serotonergic and noradrenergic pathways are also affected.
Martinez-Martin, Pablo   +6 more
core   +1 more source

Prevalence of non-motor symptoms in Parkinson’s disease [PDF]

open access: yes, 2019
Background: Parkinson’s disease is a common neurodegenerative movement disorder characterised by motor symptoms of rest tremor, bradykinesia, rigidity and postural instability and non-motor symptoms (NMS) which include neuropsychiatric symptoms, sleep ...
M., Muthuveeran   +5 more
core   +1 more source

More than a Movement Disorder: Non-Motor Features and Future Directions in Dystonia Research

open access: yesBrain Sciences
Background: Dystonia, the third most common movement disorder, is increasingly recognised as a network disorder with both motor and non-motor symptoms. Non-motor symptoms have been shown to be key determinants of quality of life in dystonia and include ...
Sanketh Rampes, Amit Batla
doaj   +1 more source

Spatial and Volumetric Characteristics of Glioblastoma: Associations With Clinical Presentation and Survival

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy